Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2015
ASCO 2015 Highlights
Trials and Tribulations: Reporting Clinical Trial Results Is a Legal and Ethical Duty
By
Kristen Chanley
Clinical Trials
July 2016, Vol 7, No 6
Susan Gubar, an ovarian cancer survivor whose life has been extended by a clinical trial, was shocked to read a recent article published online by Charles Piller on the lack of reporting of clinical trial results.
Read Article
Cost of Drugs and Affordability Don’t Always Jibe
By
Phoebe Starr
Value in Oncology
July 2016, Vol 7, No 6
An international collaborative pilot study found large differences by country in retail prices for 23 cancer drugs, with the highest retail prices in the United States and the lowest in India and South Africa. Higher prices, however, did not mean that the drugs were less affordable, according to lead investigator Daniel Goldstein, MD, Rabin Medical Center, Petach Tikvah, Israel, who presented the results at the 2016 ASCO annual meeting.
Read Article
Trabectedin: a DNA-Binding Agent That Covalently Interacts with the Minor Groove of the DNA Double Helix
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Necitumumab: an Epidermal Growth Factor Receptor Antibody
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Bavituximab: a Novel, Investigational Immunotherapy Agent Targeting Phosphatidylserine in the Vasculature of the Tumor Microenvironment
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Alectinib: an Anaplastic Lymphoma Kinase (ALK) Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Lenvatinib: a Receptor Tyrosine Kinase Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Abemaciclib (LY2835219): a Dual Inhibitor of CDK4 and CDK6
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Venetoclax (ABT-199): a Selective Inhibitor of B-Cell Lymphoma-2
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Ruxolitinib: a Kinase Inhibitor That Inhibits Overactive JAK Pathway Signaling
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Page 157 of 329
154
155
156
157
158
159
160
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
From Chaos to Clarity: Data-Driven Denial Prevention
Shawntea (Taya) Gordon, MBA, FACMPE
3.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma